Expression of type I and III interferons in experimental allergic asthma and after dsRNA-induced exacerbation

I. Mahmutovic Persson, H. Akbarshahi, A. Brandelius, L. Uller (Lund, Sweden)

Source: Annual Congress 2013 –Murine models of lung immunology
Session: Murine models of lung immunology
Session type: Poster Discussion
Number: 1581
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
I. Mahmutovic Persson, H. Akbarshahi, A. Brandelius, L. Uller (Lund, Sweden). Expression of type I and III interferons in experimental allergic asthma and after dsRNA-induced exacerbation. Eur Respir J 2013; 42: Suppl. 57, 1581

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Targeting IL33-ST2 pathway in virus-induced exacerbation of experimental asthma
Source: International Congress 2016 – Immune responses in the lung
Year: 2016

RIG-I receptors induced by dsRNA challenges in an HDM-mouse model of asthma exacerbation
Source: International Congress 2014 – Exploring molecular mechanisms of allergy and asthma in animal models
Year: 2014

PI3Kδ inhibition confer efficacy in experimental models of allergic airway inflammation
Source: International Congress 2015 – Immune mechanisms in the human lung
Year: 2015


Treatment with Syk inhibitors after establishment of disease phenotype in a chronic HDM model of allergic airways inflammation abolishes AHR and attenuates inflammatory mediator expression
Source: International Congress 2015 – New targets and modalities for the treatment of asthma and COPD
Year: 2015

Characteristics of IL-25 and allergen-induced airways fibrosis in a murine model of asthma
Source: International Congress 2015 – The immunology of allergic airway disease
Year: 2015


IL33 and TSLP involvements in influenza-induced exacerbation in a murine model of chronic asthma
Source: International Congress 2015 – Advances in asthma and allergy in animal models
Year: 2015

Adjuvant-free mouse model of allergic asthma
Source: International Congress 2014 – Asthma: clinical problems
Year: 2014

Dose-dependent differential effects of thrombin in allergic bronchial asthma
Source: Annual Congress 2013 –Murine models of lung immunology
Year: 2013


The immunomodulatory activity of protein S protects against allergic airway inflammation
Source: International Congress 2015 – Immune mechanisms in the human lung
Year: 2015

Crucial timing of a viral component exposure to exacerbate allergen-induced asthma
Source: International Congress 2016 – Clinical and molecular studies in asthma
Year: 2016

Influenza induced exacerbation is associated with steroid insensitive AHR and pulmonary inflammation in HDM-sensitised mice
Source: International Congress 2016 – Immune responses in the lung
Year: 2016


Vitamin C inhibits the diisocyanate-induced lung inflammatory response in mice
Source: International Congress 2015 – Therapeutic approaches in inflammatory lung disease
Year: 2015

Oral administration of saccharomyces cerevisiae inhibits the allergic airway response in mice
Source: Annual Congress 2013 –Preclinical models for the development of new drugs for respiratory diseases
Year: 2013

Immunomodulatory role of IL-37 in asthma pathogenesis
Source: International Congress 2016 – Immune responses in the lung
Year: 2016

TLR-3 triggered exacerbation of experimental asthma depends on IL-17 producing NK cells
Source: International Congress 2014 – TH17 and other acute asthmatic responses
Year: 2014

Characterisation of a steroid-insensitive severe asthma model
Source: International Congress 2014 – Animal models in respiratory drug development
Year: 2014

BmTI-A: A serine protease inhibitor attenuates hyperresponsiveness in an experimental model of chronic allergic inflammation in Balb/c mice
Source: International Congress 2014 – Animal models in respiratory drug development
Year: 2014

GARP reduces inflammation in a humanized mouse model of allergic airway disease
Source: International Congress 2015 – Advances in asthma and allergy in animal models
Year: 2015

Establishment of a murine asthma exacerbation model by combining OVA exposure with either RSV or influenza infection
Source: International Congress 2016 – Immune responses in the lung
Year: 2016

LATE-BREAKING ABSTRACT: IL33 drives humoral and cellular immune response in influenza-induced severe exacerbation of experimental asthma
Source: International Congress 2016 – Clinical and molecular studies in asthma
Year: 2016